½ÃÀ庸°í¼­
»óǰÄÚµå
1594680

±¤ÇÐ À̹Ì¡ ½ÃÀå : Á¦Ç°, ±â¼ú, Ä¡·á ºÐ¾ß, ÃÖÁ¾»ç¿ëÀÚ, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Optical Imaging Market by Product (Imaging Systems, Software), Technique (Fluorescence Imaging, Near Infrared Spectroscopy, Optical Coherence Tomography), Therapeutic Area, End-User, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±¤ÇÐ À̹Ì¡ ½ÃÀåÀº 2023³â¿¡ 32¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 35¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 12.51%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 73¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±¤ÇÐ À̹Ì¡Àº ÁÖ·Î »ý¹° ÀÇÇÐ ¿¬±¸ ¹× ÀÓ»ó Áø´Ü¿¡¼­ Á¶Á÷, ¼¼Æ÷ ¹× ºÐÀÚÀÇ ±¤ÇРƯ¼ºÀ» Æò°¡Çϱâ À§ÇØ ºûÀ» »ç¿ëÇÏ´Â ´Ù¾çÇÑ ±â¼úÀ» Æ÷ÇÔÇÕ´Ï´Ù. ±× Çʿ伺Àº ºñħ½ÀÀû Ư¼º¿¡¼­ ºñ·ÔµÇ¸ç, ȯÀÚÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϸ鼭 Áø´ÜÀÇ Á¤È®¼º°ú ÇØ»óµµ¸¦ ³ôÀÔ´Ï´Ù. ÁÖ·Î ÀÇ·á Áø´Ü¿¡ Àû¿ëµÇ¾î ¾È°ú, Á¾¾çÇÐ, ½ÉÇ÷°ü ¿µ»ó Áø´Ü, ½Å°æÇÐ ¿¬±¸¿¡ ÇʼöÀûÀ̸ç, ½Å¾à °³¹ß ¹× ¿¬±¸ ºÐ¾ß·ÎÀÇ ÀÀ¿ëµµ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëó´Â º´¿ø, ¿¬±¸¼Ò, Áø´Ü¼¾ÅÍ µî ´Ù¾çÇϸç, ±â¼ú ¹ßÀü°ú ¸¸¼ºÁúȯÀÇ È®»ê¿¡ ÈûÀÔ¾î ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ±¤°£¼·´ÜÃþÃÔ¿µ(OCT)°ú °°Àº À̹Ì¡ ±â¼úÀÇ ¹ßÀü, Áúº´ÀÇ Á¶±â Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·á ÅõÀÚ Áõ°¡ µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ´Â ÈÞ´ë¿ë ½Ç½Ã°£ À̹Ì¡ ¼Ö·ç¼Ç°ú À̹ÌÁö ó¸® Á¤È®µµ¸¦ ³ôÀ̱â À§ÇÑ AI ÅëÇÕ¿¡¼­ ãÀ» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÷´Ü À̹Ì¡ ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ¼÷·ÃµÈ Àü¹®°¡ÀÇ Çʿ伺 µîÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´õ ±íÀº Á¶Á÷ÃþÀ¸·Î ħÅõÇÏ´Â µ¥ ÀÖÀ¸¸ç, ±â¼úÀû ¾î·Á¿ò, ÀáÀçÀûÀÎ ºÎÁ¤È®¼º, À̹ÌÁöÀÇ ¾ÆÆ¼ÆÑÆ®¿¡ ´ëÇÑ Ãë¾à¼º µîÀÇ ¹®Á¦µµ ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ °¡´É¼ºÀº ¸ÖƼ¸ð´Þ ¿µ»ó ½Ã½ºÅÛ °³¹ß, ¿µ»ó µ¥ÀÌÅÍ¿Í ÀüÀÚÀǹ«±â·ÏÀÇ ÅëÇÕ, Å×¶ó³ë½ºÆ½½º¸¦ À§ÇÑ ¿µ»ó ó¸® °­È­¿¡ ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü°ú ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ¿Í ±â¼ú °³¹ßÀÚÀÇ Çù·Â °ü°è Áõ°¡·Î ÀÎÇØ ¿ªµ¿ÀûÀÎ ¿òÁ÷ÀÓÀ» º¸À̰í ÀÖ½À´Ï´Ù. ±â¾÷Àº Àúºñ¿ëÀÇ ÈÞ´ë¿ë ¼Ö·ç¼Ç¿¡ ÃÊÁ¡À» ¸ÂÃß°í ¸ÂÃãÇü ÀÇ·á ¹× ¿ø°ÝÀÇ·á¿Í °°Àº ½ÅÈï ºÐ¾ß¿¡¼­ÀÇ Àû¿ëÀ» È®´ëÇÔÀ¸·Î½á ¼ºÀå ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷ÀÌ ¼º°øÇϱâ À§Çؼ­´Â R&D¿¡ ÅõÀÚÇϰí, ±â¼ú °øÀ¯¸¦ À§ÇÑ Àü·«Àû Á¦ÈÞ¸¦ ÃËÁøÇϰí, ±â¼ú °ÝÂ÷¸¦ ÇØ¼ÒÇϱâ À§ÇÑ ±³À° ÇÁ·Î±×·¥ÀÇ ¿ì¼±¼øÀ§¸¦ Á¤ÇÏ¿© ÀÌ ¼ºÀå ½ÃÀå¿¡¼­ °æÀï ¿ìÀ§¸¦ È®º¸ÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023³â] 32¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â[2024³â] 35¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â[2030³â] 73¾ï 3,000¸¸ ´Þ·¯
CAGR(%) 12.51%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ±¤ÇÐ À̹Ì¡ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

±¤ÇÐ À̹Ì¡ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °Ç°­ Àå¾ÖÀÇ Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ¼±È£µµ Áõ°¡
    • Àü ¼¼°è¿¡¼­ ±ÞÁõÇÏ´Â ½Å°æ ¹× ¾È°ú ÁúȯÀÇ À¯º´·ü
    • Àúħ½À ¼ö¼ú ¹× ºñħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÁöÃâ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±¤ÇÐ À̹Ì¡ Àåºñ ¹× Àåºñ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • Çö¹Ì°æ°ú ³ª³ëÅ×Å©³î·¯ÁöÀÇ ±¤ÇÐ À̹Ì¡ÀÇ Áøº¸
    • ½Ã°¢ Àå¾Ö¸¦ ÅëÁ¦Çϱâ À§ÇÑ Á¤ºÎ Áö¿ø ±¸»ó ¹× ÅõÀÚ
  • ½ÃÀå °úÁ¦
    • ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ· ¹× ÀûÀýÇÑ »óȯ °èȹ ºÎÁ·

Porter's Five Forces: ±¤ÇÐ À̹Ì¡ ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ ÅøÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀû µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±¤ÇÐ À̹Ì¡ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ±¤ÇÐ À̹Ì¡ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ±¤ÇÐ À̹Ì¡ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

±¤ÇÐ À̹Ì¡ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, À̸¦ ÅëÇØ °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ±¤ÇÐ À̹Ì¡ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ±¤ÇÐ À̹Ì¡ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ±¤ÇÐ À̹Ì¡ ½ÃÀå¿¡¼­ ¼º°øÀ¸·Î °¡´Â ±æ Â÷Æ®

±¤ÇÐ À̹Ì¡ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ±¤ÇÐ À̹Ì¡ ½ÃÀå : Á¦Ç°º°

  • ¼­·Ð
  • À̹Ì¡ ½Ã½ºÅÛ
  • ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå ±¤ÇÐ À̹Ì¡ ½ÃÀå : ±â¼úº°

  • ¼­·Ð
  • Çü±¤ À̹Ì¡
  • ±ÙÀû¿Ü ºÐ±¤¹ý
  • ±¤°£¼· ´ÜÃþÃÔ¿µ
  • ±¤À½Çâ Åä¸ð±×·¡ÇÇ
  • ¶ó¸¸ À̹Ì¡

Á¦8Àå ±¤ÇÐ À̹Ì¡ ½ÃÀå : Ä¡·á ºÐ¾ßº°

  • ¼­·Ð
  • ½ÉÀ庴ÇÐ
  • Ä¡°ú
  • ÇǺΰú
  • ½Å°æÇÐ
  • Á¾¾çÇÐ
  • ¾È°ú

Á¦9Àå ±¤ÇÐ À̹Ì¡ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • ¿µ»ó Áø´Ü ¼¾ÅÍ
  • º´¿ø¡¤¿¬±¸±â°ü

Á¦10Àå ±¤ÇÐ À̹Ì¡ ½ÃÀå : ¿ëµµº°

  • ¼­·Ð
  • ¼ö¼úÁß
  • º´¸®

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ ±¤ÇÐ À̹Ì¡ ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±¤ÇÐ À̹Ì¡ ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±¤ÇÐ À̹Ì¡ ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

¾ð±ÞµÈ ±â¾÷

  • Abbott Laboratories
  • Agfa-Gevaert Group
  • Arcscan Inc.
  • Aspectus Imaging
  • Atlantis Wordwide
  • BC Technical by Alpha Source, Inc.
  • Beekley Corporation
  • Calyx
  • Canon Inc.
  • Carl Zeiss Meditec AG
  • ChemImage Corporation
  • CMS Imaging, Inc.
  • Cylite Pty Ltd.
  • CytoViva, Inc.
  • DirectMed Parts & Service, LLC
  • Edmund Optics Inc.
  • Etaluma, Inc.
  • Farm by Flex Ltd.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hamamatsu Photonics K.K.
  • Headwall Photonics
  • Heidelberg Engineering GmbH
  • Interim Diagnostic Imaging, LLC
  • Kibero GmbH
  • Koninklijke Philips N.V.
  • Meridian Group International
  • MXR Imaging Inc
  • Optos PLC
  • Oxford Instruments PLC
  • PerkinElmer Inc.
  • Protec GmbH & Co. KG
  • Radiant Vision Systems by Konica Minolta, Inc.
  • Seno Medical Instruments, Inc.
  • Shanghai Haobo Imaging Technology Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Sutter Instrument Company
  • Thorlabs, Inc.
  • Tomlin Medical
  • Topcon Corporation
  • Toshiba Medical Systems Corporation
  • Turner Imaging Systems
  • Universe Kogaku(America) Inc.
  • Vidisco Ltd.
  • Visiconsult GmbH
  • Visionix USA Inc.
  • White Mountain Imaging
  • Wipotec GmbH
  • XOS
KSA 24.11.29

The Optical Imaging Market was valued at USD 3.21 billion in 2023, expected to reach USD 3.58 billion in 2024, and is projected to grow at a CAGR of 12.51%, to USD 7.33 billion by 2030.

Optical imaging encompasses a diverse range of technologies that employ light to assess optical properties of tissues, cells, and molecules, primarily in biomedical research and clinical diagnostics. Its necessity stems from its non-invasive nature, enhancing precision and resolution in diagnostics while minimizing patient risk. Applied predominantly in medical diagnostics, optical imaging is critical in ophthalmology, oncology, cardiovascular imaging, and neurological studies, with burgeoning uses in drug discovery and research. End-use spans hospitals, research laboratories, and diagnostic centers, supported by technological advancements and an increasing prevalence of chronic diseases. Key growth factors include advancements in imaging technologies like optical coherence tomography (OCT), rising demand for early disease diagnosis, and increased healthcare investments. Emerging opportunities can be found in portable and real-time imaging solutions and integration of AI to enhance image processing accuracy. However, challenges such as high cost of advanced imaging systems, stringent regulatory frameworks, and a need for skilled professionals may hinder market growth. Limitations also include technical challenges in penetrating deeper tissue layers, potential inaccuracies, and susceptibility to artifacts in images. Innovation potential lies in developing multimodal imaging systems, integrating imaging data with electronic health records, and enhancing imaging for theranostics. The market remains dynamic, driven by continuous technological advancements and increasing collaborations between healthcare providers and tech developers. Companies can leverage growth opportunities by focusing on low-cost, portable solutions and expanding applications in emerging fields such as personalized medicine and telehealth. To thrive, businesses should invest in R&D, foster strategic alliances for technology sharing, and prioritize training programs to address the skills gap, ensuring competitive advantage in this growing market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.21 billion
Estimated Year [2024] USD 3.58 billion
Forecast Year [2030] USD 7.33 billion
CAGR (%) 12.51%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Optical Imaging Market

The Optical Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing patient preference for early diagnosis and treatment of health disorders
    • Surging prevalence of neurological and ophthalmological disorders worldwide
    • Increasing consumer expenditures on minimally and non-invasive surgeries
  • Market Restraints
    • High costs associated with optical imaging equipment and devices
  • Market Opportunities
    • Advancements in optical imaging for microscopy and nanotechnology
    • Supportive government initiatives and investments to control visual impairments
  • Market Challenges
    • Limited availability of skilled professionals and lack of appropriate reimbursement plans

Porter's Five Forces: A Strategic Tool for Navigating the Optical Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Optical Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Optical Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Optical Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Optical Imaging Market

A detailed market share analysis in the Optical Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Optical Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Optical Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Optical Imaging Market

A strategic analysis of the Optical Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Optical Imaging Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agfa-Gevaert Group, Arcscan Inc., Aspectus Imaging, Atlantis Wordwide, BC Technical by Alpha Source, Inc., Beekley Corporation, Calyx, Canon Inc., Carl Zeiss Meditec AG, ChemImage Corporation, CMS Imaging, Inc., Cylite Pty Ltd., CytoViva, Inc., DirectMed Parts & Service, LLC, Edmund Optics Inc., Etaluma, Inc., Farm by Flex Ltd., FUJIFILM Holdings Corporation, GE Healthcare, Hamamatsu Photonics K.K., Headwall Photonics, Heidelberg Engineering GmbH, Interim Diagnostic Imaging, LLC, Kibero GmbH, Koninklijke Philips N.V., Meridian Group International, MXR Imaging Inc, Optos PLC, Oxford Instruments PLC, PerkinElmer Inc., Protec GmbH & Co. KG, Radiant Vision Systems by Konica Minolta, Inc., Seno Medical Instruments, Inc., Shanghai Haobo Imaging Technology Co., Ltd., Shimadzu Corporation, Siemens Healthineers, Sutter Instrument Company, Thorlabs, Inc., Tomlin Medical, Topcon Corporation, Toshiba Medical Systems Corporation, Turner Imaging Systems, Universe Kogaku (America) Inc., Vidisco Ltd., Visiconsult GmbH, Visionix USA Inc., White Mountain Imaging, Wipotec GmbH, and XOS.

Market Segmentation & Coverage

This research report categorizes the Optical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Imaging Systems and Software.
  • Based on Technique, market is studied across Fluorescence Imaging, Near Infrared Spectroscopy, Optical Coherence Tomography, Photoacoustic Tomography, and Raman Imaging.
  • Based on Therapeutic Area, market is studied across Cardiology, Dentistry, Dermatology, Neurology, Oncology, and Ophthalmology.
  • Based on End-User, market is studied across Diagnostic Imaging Centers and Hospitals & Research Laboratories.
  • Based on Application, market is studied across Intraoperative Imaging and Pathological Imaging.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing patient preference for early diagnosis and treatment of health disorders
      • 5.1.1.2. Surging prevalence of neurological and ophthalmological disorders worldwide
      • 5.1.1.3. Increasing consumer expenditures on minimally and non-invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with optical imaging equipment and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in optical imaging for microscopy and nanotechnology
      • 5.1.3.2. Supportive government initiatives and investments to control visual impairments
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled professionals and lack of appropriate reimbursement plans
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Optical Imaging Market, by Product

  • 6.1. Introduction
  • 6.2. Imaging Systems
  • 6.3. Software

7. Optical Imaging Market, by Technique

  • 7.1. Introduction
  • 7.2. Fluorescence Imaging
  • 7.3. Near Infrared Spectroscopy
  • 7.4. Optical Coherence Tomography
  • 7.5. Photoacoustic Tomography
  • 7.6. Raman Imaging

8. Optical Imaging Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Dentistry
  • 8.4. Dermatology
  • 8.5. Neurology
  • 8.6. Oncology
  • 8.7. Ophthalmology

9. Optical Imaging Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Imaging Centers
  • 9.3. Hospitals & Research Laboratories

10. Optical Imaging Market, by Application

  • 10.1. Introduction
  • 10.2. Intraoperative Imaging
  • 10.3. Pathological Imaging

11. Americas Optical Imaging Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Optical Imaging Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Optical Imaging Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Ametek buys optical solutions provider Navitar
    • 14.3.2. Photon etc. acquires Kaer Labs, confirming its position in the pre-clinical optical imaging market
    • 14.3.3. Precision Optics Acquires Lighthouse Imaging, a Leading Optical Imaging Electronics and Systems Company
    • 14.3.4. Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart
    • 14.3.5. Canon Singapore Launches Innovative Wide-field Swept Source Optical Coherence Tomography
    • 14.3.6. Abbott launches AI-powered coronary OCT imaging system in Europe
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agfa-Gevaert Group
  • 3. Arcscan Inc.
  • 4. Aspectus Imaging
  • 5. Atlantis Wordwide
  • 6. BC Technical by Alpha Source, Inc.
  • 7. Beekley Corporation
  • 8. Calyx
  • 9. Canon Inc.
  • 10. Carl Zeiss Meditec AG
  • 11. ChemImage Corporation
  • 12. CMS Imaging, Inc.
  • 13. Cylite Pty Ltd.
  • 14. CytoViva, Inc.
  • 15. DirectMed Parts & Service, LLC
  • 16. Edmund Optics Inc.
  • 17. Etaluma, Inc.
  • 18. Farm by Flex Ltd.
  • 19. FUJIFILM Holdings Corporation
  • 20. GE Healthcare
  • 21. Hamamatsu Photonics K.K.
  • 22. Headwall Photonics
  • 23. Heidelberg Engineering GmbH
  • 24. Interim Diagnostic Imaging, LLC
  • 25. Kibero GmbH
  • 26. Koninklijke Philips N.V.
  • 27. Meridian Group International
  • 28. MXR Imaging Inc
  • 29. Optos PLC
  • 30. Oxford Instruments PLC
  • 31. PerkinElmer Inc.
  • 32. Protec GmbH & Co. KG
  • 33. Radiant Vision Systems by Konica Minolta, Inc.
  • 34. Seno Medical Instruments, Inc.
  • 35. Shanghai Haobo Imaging Technology Co., Ltd.
  • 36. Shimadzu Corporation
  • 37. Siemens Healthineers
  • 38. Sutter Instrument Company
  • 39. Thorlabs, Inc.
  • 40. Tomlin Medical
  • 41. Topcon Corporation
  • 42. Toshiba Medical Systems Corporation
  • 43. Turner Imaging Systems
  • 44. Universe Kogaku (America) Inc.
  • 45. Vidisco Ltd.
  • 46. Visiconsult GmbH
  • 47. Visionix USA Inc.
  • 48. White Mountain Imaging
  • 49. Wipotec GmbH
  • 50. XOS
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦